1. Home
  2. GSIT vs ADAG Comparison

GSIT vs ADAG Comparison

Compare GSIT & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GSI Technology

GSIT

GSI Technology

N/A

Current Price

$4.78

Market Cap

196.4M

Sector

Technology

ML Signal

N/A

Logo Adagene Inc.

ADAG

Adagene Inc.

N/A

Current Price

$2.76

Market Cap

222.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GSIT
ADAG
Founded
1995
2011
Country
United States
China
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
196.4M
222.2M
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
GSIT
ADAG
Price
$4.78
$2.76
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $9.91
AVG Volume (30 Days)
★ 427.7K
274.0K
Earning Date
10-29-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $25,122,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.85
$129.59
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 22.44
N/A
52 Week Low
$4.51
$1.44
52 Week High
$18.14
$4.85

Technical Indicators

Market Signals
Indicator
GSIT
ADAG
Relative Strength Index (RSI) 33.72 35.41
Support Level $4.69 $1.50
Resistance Level $5.86 $3.40
Average True Range (ATR) 0.22 0.27
MACD -0.04 -0.01
Stochastic Oscillator 6.20 14.79

Price Performance

Historical Comparison
GSIT
ADAG

About GSIT GSI Technology

GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia and customers segregated as-Contract manufacturers, Distribution and OEMs. In addition, it serves the ongoing needs of the military, aerospace and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and USA.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

Share on Social Networks: